年間 4 号発行
ISSN 印刷: 1050-6934
ISSN オンライン: 1940-4379
Indexed in
Prosthetic Heart Valves: Why Biological?
要約
The replacement of heart valves only became feasible after the development of the heartlung machine in 1953. Two groups of prosthetic heart valves were subsequently developed: biological valves that do not require anticoagulation and mechanical valves that require life-long anticoagulation with Coumadin. The incidence of heart surgery and the demographics of patients who require heart valve surgery vary worldwide; these factors influence the choice of prosthetic valve for the individual patient and are briefly reviewed. Improved biological tissue-fixation methods are also increasing the durability of biological prosthetic valves and will further favor the implantation of biological valves in the future.
-
Griffiths Leigh G., Choe Leila, Lee Kelvin H., Reardon Kenneth F., Orton E. Christopher, Protein extraction and 2-DE of water- and lipid-soluble proteins from bovine pericardium, a low-cellularity tissue, ELECTROPHORESIS, 29, 22, 2008. Crossref
-
Yankah C.A., Siniawski H., Hetzer R., Repair of rheumatic mitral valve incompetence: surgical challenges and clinical results, in Mitral Valve Repair, 2011. Crossref
-
Vasudevan Balamurugan, Chang Qing, Wang Bin, Huang Siyang, Sui Yulong, Zhu Wenjie, Fan Qing, Song Yisheng, Effect of intracellular uptake of nanoparticle-encapsulated trehalose on the hemocompatibility of allogeneic valves in the VS83 vitrification protocol, Nanobiomedicine, 7, 2020. Crossref